Bengaluru: Elmentoz Analysis Pvt. Ltd., a deep-tech biotechnology firm pioneering precision animal well being diet and good feed options for poultry, aquaculture, and pet meals, has introduced the closure of its first seed funding spherical from angel buyers in India and Norway. With this funding, Elmentoz is establishing India’s largest BSF-based good protein facility, able to processing 2,000 MT per 30 days of commercial byproducts by means of its proprietary superior automation applied sciences.
The ability is scheduled to open to the market in January 2026, marking a serious milestone for India’s sustainable feed and next-generation good protein trade.
This capital infusion will speed up Elmentoz’s mission to construct sustainable, next-generation biofeed options that handle India’s heavy import reliance on purposeful feed components, scale back biosecurity vulnerabilities—together with the rising problem of antimicrobial resistance—and enhance farmers’ profitability.
It strengthens our India-first, research-driven insect protein platform, delivering measurable reductions in land use, water consumption, and carbon footprints.
Elmentoz’s IP-led innovation platform integrates genomics, proteomics, superior automation, and cGMP manufacturing to ship AMP-fortified immune-smart premixes, good protein formulations, and purposeful oil elements below its flagship product strains—ELGROW and ELTIDE. The corporate’s precision-nutrition strategy enhances intestine well being, improves feed conversion, and strengthens illness resilience, changing antibiotic development promoters (AGPs) with purposeful immuno-nutrition options.
Seed proceeds will probably be used to:
• Scale India’s first superior automated cGMP smart-protein manufacturing facility
• Increase ELGROW and ELTIDE product portfolios
• Advance antimicrobial peptide (AMP) expertise and platform growth
• Strengthen strategic worldwide partnerships
• Develop analysis, manufacturing, and business groups to assist fast growth
Commenting on the capital infusion, Dr. Jayashankar Das, Founder and CEO, Elmentoz Analysis Pvt. Ltd., stated: “India, as an agrarian financial system, should prioritise dietary safety, not simply meals safety. Our analysis pushed insect protein and antimicrobial peptide platforms ship constant amino acid profiles, higher intestine well being, and antibiotic free efficiency throughout poultry, aquaculture, and pet segments. With rigorous genomics, proteomics, and superior cGMP manufacturing, we are able to change AGPs with focused purposeful feeds which can be safer, smarter, and extra resilient for farmers and feed producers.”
Leave a Reply